A drug originally developed to help the heart heal after a heart attack may also speed up recovery from kidney injury, according to new research from the University of California, Los Angeles (UCLA).
The study, published in Cell Stem
Cell, found that the experimental drug, known as AD-NP1, improved kidney repair
and reduced scarring in mice by blocking a protein that interferes with the
body’s natural healing process.
The findings raise hopes that the treatment, which has already been cleared by the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials for heart
.jpg)
.jpg)
.jpg)

.jpg)

